foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Top 4 Tips you need to prepare for Biotech IPO

Biotech companies have fared well recently in the IPO market in both the US...

Read More

Placements, Clinical Studies and the Utility of Pa...

In this interview, we speak to Andrew Newland, the CEO of ANGLE plc, a comm...

Read More

One Year on from IPO: Motif Bio’s Commercialisatio...

Graham Lumsden, CEO of Motif Bio, talks to Biotech and Money about the comm...

Read More

Shield Therapeutics raises £32.5M in 2016 AIM Debu...

Carl Sterritt, CEO of Shield Therapeutics, talks to Biotech and Money about...

Read More

ISSUE 9, 2016 Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

The Californian biotech who brought a $100m IPO to...

Verseon was founded in 2002. Its proprietary drug discovery platform, devel...

Read More

From developing highly differentiated ‘best-in-cl...

Redx is focused on the development of proprietary, small molecule therapeut...

Read More

Life science approaches to public markets: AIM, Na...

The following transcript comes from Approaches to public markets: AIM, Nasd...

Read More

How to make a £3bn life science company

What you will learn by reading this post: How Jim Phillips, CEO, Midatech P...

Read More

Add Your Response